Sort
40,608 grants matching “prostate cancer”
SOUTHWEST ONCOLOGY GROUP CA-13612
$422,947University Of Arizona · U10 · FY2001 · CA
CALGB
$422,936Ohio State University · U10 · FY2000 · CA
Frontiers in Bone Metastatic Models for Prostate Cancer
$422,874Leslie Ann Caromile · University Of Connecticut Sch Of Med/Dnt · R21 · FY2024 · CA
A Serum Marker for Aggressive Prostate Cancer
$422,810Donna M Peehl · Stanford University · R01 · FY2007 · CA
Role of SLC39A8 (ZIP8) in selenite transport
$422,803Zijuan Liu · Oakland University · R15 · FY2013 · ES
Molecular Cytogenetics Core
$422,797Anna Roschke · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Evaluate long-term prognosis of localized prostate cancer following initial radia
$422,740Grace Lu-Yao · Univ Of Med/Dent Nj-R W Johnson Med Sch · RC1 · FY2009 · CA
Chemical markers of heterocyclic aromatic amines for human biomonitoring
$422,733Robert J. Turesky · University Of Minnesota · R01 · FY2017 · CA
Lineage-specific signaling and targeting of PI3K gamma in myeloid malignancies
$422,717Kris C. Wood · Duke University · R01 · FY2022 · CA
Development of a Novel TGF-beta Antagonist for Treating Hepatic Fibrosis
$422,669Jung S. Huang · Saint Louis University · RC1 · FY2009 · AA
Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer
$422,647John L. Cleveland · Scripps Research Institute, The · R01 · FY2010 · CA
Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer
$422,647John L. Cleveland · Scripps Research Institute, The · R01 · FY2009 · CA
Advanced tools for using ancient DNA to study biology and history
$422,606David Emil Reich · Harvard Medical School · R01 · FY2025 · HG
Advanced tools for using ancient DNA to study biology and history
$422,605David Emil Reich · Harvard Medical School · R01 · FY2024 · HG
Addressing Urban Rural Disparities in Cancer: The Case for Registry Expansion
$422,585Cathy J. Bradley · University Of Colorado Denver · R01 · FY2019 · CA
Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis
$422,579Yun Rose Li · Beckman Research Institute/City Of Hope · DP5 · FY2023 · OD
The role of exercise in vaccine-mediated immunity
$422,576John Greiner · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
$422,535Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Project 4: The BRCA Network in Medulloblastoma Responses to Replication Stress
$422,453Zhiyuan Shen · Rbhs -Cancer Institute Of New Jersey · P01 · FY2022 · CA
SAMBAI-Columbia
$422,413Gary W Miller · Columbia University Health Sciences · OT2 · FY2024 · CA
Genetic and Molecular Basis of Rapamycin Sensitivity
$422,405Xiaofeng Steven Zheng · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2007 · CA
Endothelin Mechanisms in Metastic Prostate Cancer Pain
$422,391Gary R Strichartz · Brigham And Women'S Hospital · R01 · FY2012 · CA
Biochemical Pathways of 12-HETE and 12-KETE Metabolism
$422,379Joshua Rokach · Florida Institute Of Technology · R01 · FY2010 · HL
Immunogenic sugar moieties of prostate cancers
$422,371Denong Wang · Stanford University · U01 · FY2007 · CA
Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
$422,350William J Aronson · University Of California Los Angeles · R01 · FY2022 · CA